Non categorizzato FDA halts use of Evusheld due to low effectiveness Gennaio 27, 2023 0 commenti The Food and Drugs Administration withdrew AstraZeneca’s COVID-19 antibody treatment from the market due to the medicine not being effective against 93% of coronavirus subvariants currently regist… About the author:
Get involved!
Comments